Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Scotland puts Dx and labs input at centre of new TB action plan

This article was originally published in Clinica

Executive Summary

Scotland has announced a TB Action Plan with a strong focus on “increasing the effectiveness” of diagnostic tests, laboratory services and surveillance activities relating to tuberculosis. The plan, which is targeted at health professionals, is in response to a recently observed rise in TB rates. “Scotland's rate of TB has been relatively low and stable, but recently there has been evidence that the number of cases, while still low, is increasing,” said the Scottish government. “There are various reasons why the number of cases may be increasing, including the emergence of drug resistant strains, the continued prevalence of HIV and increased movement of people between countries,” it added.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT096940

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel